Featured Posts
Blog
Don’t hinder biosimilar development
In its most recent legislative session, the Florida legislature considered precluding pharmacy benefit managers (PBMs) from holding an investment interest in biosimilar manufacturing. That…
Blog
The unseen costs of banning PBM-owned pharmacies in Tennessee
Tennessee lawmakers recently passed the FAIR Rx Act, which would bar companies from owning pharmacies while also operating a pharmacy benefit manager (PBM) and…
Blog
FDA’s Moderna decision demonstrates how science and government are incompatible
Last week, the FDA announced that it would not be considering Moderna’s application for a new flu vaccine because the control group Moderna used…
Search Posts
Wall Street Journal
The Bivalent Booster Boondoggle
The public-health bureaucracy is adopting yet another excessive vaccination policy. On Oct. 12 the Food and Drug Administration authorized bivalent Covid-19 boosters from …
Blog
One Year on, FDA Sodium Guidance Still Wanting
It is the one year anniversary of the Food and Drug Administration’s (FDA) Guidance for Industry setting out goals to reduce sodium content in…
New York Post
California Makes it Illegal for Doctors to Disagree with Politicians
Conformity of thought is now required whether it is online, on college campuses, or, if you are in California, in a physician-patient relationship. PayPal recently…
News Release
Court Rules Against Vaccine/Mask Mandates Imposed by Federal Agency
Today, a federal judge in Louisiana ruled the federal government cannot require Head Start program teachers, staff and volunteers be vaccinated against COVID-19 nor that…
New York Post
It seems clear Dems pressured the FDA to delay the COVID vaccine to hurt Trump
For every week we didn’t have a COVID-19 vaccine, more people died, more children were kept out of school, and more damage was done to…
News Release
Judge Rules Illumina-Grail Merger is Legal Despite FTC Antitrust Accusations
In a decision reached today, an administrative judge ruled that a proposed merger between Illumnia and Grail can proceed after ruling against a move…